Skip to main content
logo
Palomino Laboratories Inc. (PALX)
OTCMKTS · Delayed Price · Currency is USD
14.95
+2.20 (17.25%)
At close: Aug 10, 2026

Palomino Laboratories Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Net Income
-5.18-3.16-0.02-0
Stock-Based Compensation
1.531.44--
Other Operating Activities
0.220.460.01-0.01
Change in Accounts Payable
0.270.2800
Change in Other Net Operating Assets
-0.3-0.31-0-
Operating Cash Flow
-3.44-1.28-0-0.01
Operating Cash Flow Growth
----

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Long-Term Debt Issued
-1.7--
Total Debt Issued
1.71.7-0.17
Short-Term Debt Repaid
--0--
Long-Term Debt Repaid
--0.35--
Total Debt Repaid
-0.35-0.35--
Net Debt Issued (Repaid)
1.341.34-0.17
Issuance of Common Stock
24.589.76-0
Other Financing Activities
-3.5-1.83--
Financing Cash Flow
22.429.27-0.17

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Net Cash Flow
17.727.99-00.15

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Levered Free Cash Flow
-2.85-0.22-0.01-
Unlevered Free Cash Flow
-2.85-0.22-0.01-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Change in Working Capital
-0.03-0.02-00